Piotr Bartnicki - Publications

Relationships between functional performance, body composition, and biochemical markers of inflammation in young men who play team sports.

Journal: Scientific reports

Published: April 19, 2026

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors as a New Treatment Option for Anemia in Chronic Kidney Disease.

Journal: Biomedicines

Published: June 23, 2024

Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: March 11, 2021

Selected cardiovascular risk factors in early stages of chronic kidney disease.

Journal: International urology and nephrology

Published: July 08, 2019

Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients.

Journal: International urology and nephrology

Published: August 05, 2017

Hemodialysis Decreases the Concentration of Accumulated Plant Phenols in the Plasma of Patients on Maintenance Dialysis: Influence of Residual Renal Function.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: March 26, 2017

Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients?

Journal: Current pharmaceutical design

Published: March 06, 2017

The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis.

Journal: International urology and nephrology

Published: October 10, 2016

Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.

Journal: Expert opinion on pharmacotherapy

Published: September 22, 2016

Basic inflammatory indices and chosen neutrophil receptors expression in chronic haemodialysed patients.

Journal: Central-European journal of immunology

Published: June 20, 2016

Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients.

Journal: Current vascular pharmacology

Published: May 27, 2016

Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease.

Journal: Oxidative medicine and cellular longevity

Published: November 25, 2015